News

TipRanks Financial
tipranks.com > news > company-announcements > sprix-delivers-strong-quarterly-growth-and-confirms-dividend-eyes-further-gains-in-fy2026

Sprix Delivers Strong Quarterly Growth and Confirms Dividend, Eyes Further Gains in FY2026 - TipRanks.com

Sprix Delivers Strong Quarterly Growth and Confirms Dividend, Eyes Further Gains in FY2026 - TipRanks.com8+ min ago   (184+ words) The latest update is out from Sprix Ltd. ( (JP:7030) ). Sprix Inc. reported strong results for the quarter ended 31 December 2025, with net sales rising 12.0% year on year to "9.75 billion and profit attributable to owners of the parent climbing 30.8% to "954 million. Earnings…...

TipRanks Financial
tipranks.com > news > here-are-singapores-top-5-analysts-of-2025-as-measured-by-tipranks

Here Are Singapore’s Top 5 Analysts of 2025, as Measured by TipRanks - TipRanks.com

Here Are Singapore’s Top 5 Analysts of 2025, as Measured by TipRanks - TipRanks.com45+ min ago   (328+ words) In 2025, Singapore's economy expanded by 5%, beating estimates as the global demand for artificial intelligence infrastructure propelled local manufacturing. With the TipRanks Expert Center, TipRanks has identified the top five analysts who helped investors navigate the market amid the ups and…...

TipRanks Financial
tipranks.com > news > company-announcements > yamazaki-baking-lifts-profits-and-dividend-on-strong-2025-results

Yamazaki Baking Lifts Profits and Dividend on Strong 2025 Results - TipRanks.com

Yamazaki Baking Lifts Profits and Dividend on Strong 2025 Results - TipRanks.com47+ min ago   (137+ words) Give Your Portfolio Some Love - 70% off Premium Yamazaki Baking Co ( 2212 +2.17% " ) has provided an update. The most recent analyst rating on 2212 +2.17% " stock is a Buy with a Yen4200.00 price target. To see the full list of analyst forecasts on Yamazaki Baking Co…...

TipRanks Financial
tipranks.com > news > private-companies > falconx-emphasizes-institutional-crypto-growth-through-derivatives-and-regulatory-clarity

FalconX Emphasizes Institutional Crypto Growth Through Derivatives and Regulatory Clarity - TipRanks.com

FalconX Emphasizes Institutional Crypto Growth Through Derivatives and Regulatory Clarity - TipRanks.com1+ hour, 1+ min ago   (265+ words) FalconX Emphasizes Institutional Crypto Growth Through Derivatives and Regulatory Clarity'TipRanks FalconX Emphasizes Institutional Crypto Growth Through Derivatives and Regulatory Clarity A LinkedIn post from FalconX highlights a panel at Consensus 2026 Hong Kong featuring the firm's Global Co-Head of Markets, Joshua…...

TipRanks Financial
tipranks.com > news > private-companies > vast-data-emphasizes-unified-infrastructure-strategy-for-enterprise-ai-scaling

VAST Data Emphasizes Unified Infrastructure Strategy for Enterprise AI Scaling - TipRanks.com

VAST Data Emphasizes Unified Infrastructure Strategy for Enterprise AI Scaling - TipRanks.com1+ hour, 1+ min ago   (230+ words) VAST Data Emphasizes Unified Infrastructure Strategy for Enterprise AI Scaling'TipRanks VAST Data Emphasizes Unified Infrastructure Strategy for Enterprise AI Scaling According to a recent LinkedIn post from VAST Data, the company is emphasizing the need for unified data infrastructure to…...

TipRanks Financial
tipranks.com > news > company-announcements > carmax-appoints-keith-barr-as-new-president-and-ceo

CarMax Appoints Keith Barr as New President and CEO - TipRanks.com

CarMax Appoints Keith Barr as New President and CEO - TipRanks.com1+ hour, 17+ min ago   (120+ words) CarMax ( (KMX) ) has issued an update. The most recent analyst rating on (KMX) stock is a Hold with a $49.00 price target. To see the full list of analyst forecasts on CarMax stock, see the KMX Stock Forecast page. Spark's Take…...

TipRanks Financial
tipranks.com > news > ratings > immunome-differentiated-oncology-portfolio-and-adc-platform-underpin-buy-rating-and-40-price-target-ratings

Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target - TipRanks.com

Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target - TipRanks.com1+ hour, 19+ min ago   (258+ words) Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target'TipRanks Give Your Portfolio Some Love - 70% off Premium Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target Immunome (IMNM) has received a new Buy…...

TipRanks Financial
tipranks.com > news > company-announcements > restaurant-brands-international-posts-higher-2025-sales-and-earnings-meets-leverage-targets

Restaurant Brands International Posts Higher 2025 Sales and Earnings, Meets Leverage Targets - TipRanks.com

Restaurant Brands International Posts Higher 2025 Sales and Earnings, Meets Leverage Targets - TipRanks.com1+ hour, 25+ min ago   (131+ words) Restaurant Brands International ( (QSR) ) just unveiled an update. The most recent analyst rating on (QSR) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on Restaurant Brands International stock, see the QSR Stock…...

TipRanks Financial
tipranks.com > news > company-announcements > navamedic-delivers-record-q4-revenue-on-addiction-portfolio-and-antibiotics-growth

Navamedic Delivers Record Q4 Revenue on Addiction Portfolio and Antibiotics Growth - TipRanks.com

Navamedic Delivers Record Q4 Revenue on Addiction Portfolio and Antibiotics Growth - TipRanks.com1+ hour, 31+ min ago   (33+ words) Navamedic ASA ( (DE:N1A) ) has issued an announcement. More about Navamedic ASA Average Trading Volume: 15,446 Current Market Cap: NOK537.2M For detailed information about N1A stock, go to TipRanks" Stock Analysis page....

TipRanks Financial
tipranks.com > news > company-announcements > intercorp-financial-services-reports-unaudited-fourth-quarter-2024-results

Intercorp Financial Services Reports Unaudited Fourth-Quarter 2024 Results - TipRanks.com

Intercorp Financial Services Reports Unaudited Fourth-Quarter 2024 Results - TipRanks.com1+ hour, 55+ min ago   (115+ words) Intercorp Financial Services ( (IFS) ) has provided an announcement. The most recent analyst rating on (IFS) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on Intercorp Financial Services stock, see the IFS Stock…...